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General methods
PCR and subcloning were performed as described elsewhere 1 . Yeast manipulations were performed as described elsewhere 1, 2 . Unless otherwise noted, cells were grown in synthetic dextrose complete (SDC) media consisting of Brent Supplemental Media (MP Biomedicals, Solon, OH), yeast nitrogen base without amino acids and ammonium sulfate (BD, Franklin Lakes, NJ), and dextrose (Sigma-Aldrich, St Louis, MO).
Strains
We list strains used in this study in Supplementary Information Table S1 . We used ACL379 as a parent strain, which is derived from YAS245-5C (can1::HO-CAN1 ho::HO-ADE2 ura3 ade2 leu2 trp1 his3), itself a W303 derivative 3 .
Construction of TCY3057 is detailed elsewhere 4 . We constructed a fus3-as2 derivative of this strain, RY2013 in two steps. First, we replaced the FUS3 gene with a natMX4 cassette 5 by PCR-mediated onestep gene deletion 6 , and confirmed deletion both by colony PCR and by altered halos in halo assays 2 . We then digested pES1002 (pRS406-fus3-as2) at a unique MfeI site and then integrated linear DNA into the FUS3 promoter 2 and selected for colonies that grew on uracil-deficient media. We confirmed integration by identifying cells that displayed 1) pheromone-induced growth arrest and characteristic formation of mating projections ("shmooing") when grown in medium with 100 nM pheromone, and 2) lack of growth arrest and shmooing when grown in medium with 100 nM pheromone and 10 µΜ 1-NM-PP1. We constructed the ΔSST2 derivative of this strain, RY2024, by replacing the SST2 gene with a hphMX4 deletion cassette 5 by PCR-mediated gene deletion.
We constructed the RY1130b in the following way. We first replaced the DIG1 gene with a kanMX6 cassette 7 and the STE12 gene with TRP1 7 by PCR-mediated gene deletion. We then linearized pRY1001 (pRS405 P STE12 -CFP-Ste12) by digestion with BsiWI, integrated it into the STE12 promoter, and selected for colonies that grew on leucine-deficient media. We scanned many colonies by fluorescence microscopy and found that the majority of colonies had nuclear CFP fluorescence intensities barely above background, but did express CFP-Ste12, as determined by Western blots using polyclonal rabbit antibodies raised against Ste12 (a generous gift from Ira Herskowitz, UCSF) and monoclonal anti-GFP antibodies (JL-8, Clontech). We picked one of these transformants with low nuclear CFP fluorescence (RY2026) and assumed it contains a single integrated copy of pRY1001. We found two other colonies with apparent integer multiple higher levels of average nuclear CFP intensity, RY2027 and RY2005, which we interpreted as multiple tandem integrations 8 of pRY1001 (two and three copies, respectively). By quantitative Western blots, we measured apparent integer multiple increases in steady-state CFPSte12 protein abundance levels in RY2026, RY2027, and RY2005 (Supplemental Materials Fig. 2a) , which is also consistent with 1, 2, and 3 integrations of pRY1001, respectively. To create our base FRET strain RY1130b, we first linearized pRY1004 (pRS406 P DIG1 -Dig1-YFP) by digestion with BstEII, integrated it into RY2005 in the DIG1 promoter, and selected for colonies that grew on both leucineand uracil-deficient media to create RY1130. We confirmed integration of pRY1004 by confirming nuclear YFP fluorescence, and picked a transformant with an average nuclear YFP fluorescence above background that was most common and assumed that this was a single integrant. We then made this strain (RY1130) auxotrophic for uracil by transforming cells with a short PCR product containing 40 bp homology to both the 5' and 3' ends of the URA3 gene and selecting for colonies that grew on media containing 5-fluoro-orotic-acid (5-FOA, Sigma-Aldrich). We confirmed URA3 deletion by colony PCR and by uracil-dependent growth. RY1130 and RY1130b were indistinguishable using all assays in this work (loss of FRET, MAP kinase phosphorylation, growth arrest, transcriptional output; data not shown).
We also constructed RY2025, a "dark" acceptor version of RY1130 with the YFP in Dig1-YFP containing a Q70N mutation ("YFPdark" 9 ; see below), for estimation of FRET efficiency. First, we created RY2005 by plating RY1130 on 5-FOA plates and selecting for colonies that lost the integrated pRS406 P DIG1 -Dig1-YFP. We confirmed loss of Dig1YFP by Western blots, using polyclonal rabbit antiDig1 antibodies made and characterized by David Pincus and Orna Resnekov (manuscript in preparation). We linearized pRY1004d by digestion at a unique BstEII site and transformed it into RY2005 to make RY2025. We confirmed single integration by comparing Dig1-YFP and Dig1-YFPdark protein abundances in RY1130b and RY2025, respectively, by quantitative Western blots, and then confirmed lack of nuclear YFP fluorescence in RY2025 by fluorescence microscopy. We likewise confirmed identical levels of CFP-Ste12 in RY1130b and RY2025 by quantitative Western blots.
We constructed RY1133b by replacing the endogenous KSS1 gene in RY1130b with the kss1-as2 allele in pES1004 (pRS406 kss1-as2-trunc) by two-step integration-excision gene replacement 2 . We similarly constructed RY1134b by replacing the endogenous FUS3 gene in RY1130b with the fus3-as2 allele from pES1002 (pRS406 fus3-as2), and RY1137b by similarly replacing FUS3 in RY1133b with fus3-as2. We linearized pES1004 plasmid DNA by digesting at a unique BsiWI to integrate in the 5' end of the KSS1 gene, upstream of the E94A mutation site; for pES1002, we digested with MfeI to integrate into the FUS3 promoter region (1000 bp region upstream of the start codon). We confirmed gene replacement by altered DdeI restriction digestion patterns of colony PCR products. We made RY1135b by replacing the KSS1 gene in RY1134b with an hphMX4 cassette using PCR-mediated gene replacement.
We made versions of RY1130b, RY1135b, and RY1137b with P PRM1 -YFP transcriptional reporters (RY1130bPY, RY1135bPY, and RY1137bPY, respectively) by replacing the PRM1 open reading frame in each with a YFP-His3MX6 cassette from pYFP-His3MX6 3 by PCR-mediated gene replacement.
We made strains RY700, RY701, RY702, RY2052b, RY2053, and RY2055 from the W303 derivative ACL387 10 . To make RY700, we deleted FUS3 in ACL387 by PCR-mediated gene replacement with a TRP1 cassette 7 . To make RY701, we deleted KSS1 in ACL387 by PCR-mediated gene replacement with a TRP1 cassette 7 . To make RY702, we deleted KSS1 in RY700 by PCR-mediated gene replacement with a kanMX6 cassette 7 . RY2052b was made by replacing FUS3 in ACL387 with the fus3-as2 allele by two-step integration-excision gene replacement 2 using plasmid pES1002. We made RY2053 by deleting KSS1 in RY2052b by PCR-mediated gene replacement with a kanMX6 cassette. RY2055 was made by replacing KSS1 with the kss1-as2 allele in RY700 by two-step integrationexcision gene replacement 2 using plasmid pES1004.
We made RY2073 by integrating pGP1001 into TCY3154 10 . To do this, we linearized the plasmid at a unique AvrII restriction site in between the two LYP1 sequences and transformed yeast with the linearized plasmid. We selected for integrants by plating the cells on uracil-deficient plates containing the toxic lysine analog thialysine, which selected for the presence of the URA3 cassette and for the absence of LYP1 function. We confirmed integration by checking that the thialysine resistant strains expressed mRFP constitutively by microscopy.
We made RY2077 (sst2-T134A) in two steps. First, in TC3057, we replaced the nucleotides corresponding to threonine 134 in SST with the Candida albicans URA3 knockout casette 11 by PCRmediated gene replacement. We confirmed integration by PCR and by increased sensitivity to pheromone in halo assays, indicative of a disruption in Sst2. We then replaced the inserted URA3 sequence by transforming, into this strain, a double-stranded oligonucleotide consisting of 40 nucleotides upstream of the nucleotides corresponding to threonine 134 in SST2, the nucleotides GCA (corresponding to an alanine), and 40 nucleotides downstream of amino acid 134 in SST2. We selected for transformants by growth on media containing 5-FOA. We confirmed the T134A mutation by direct sequencing.
Plasmids
We list plasmids used in this study in Supplementary Information Table S2 . In order to make pES1002 and pES1004, we performed PCR-mediated mutagenesis to introduce a Q93A mutation into Fus3, previously identified as a sensitizing mutation 12 , and an E94A mutation in Kss1, identified by sequence alignment with Fus3, using ACL379 genomic DNA as a template. For pES1002, we included 1000 bases of sequence upstream of the start codon and 401 bases downstream of the stop codon in addition to the gene; for pES1004, we included bases 22-1107 from the KSS1 gene and 401 bases downstream of the stop codon. We also introduced a 5' KpnI restriction site and a 3' NotI restriction site to each PCR product. We then subcloned these into pRS406 vectors cut with KpnI and NotI. We confirmed correct coding region sequences by direct sequencing.
We made pRY1001as follows. First, using ACL379 genomic DNA we amplified the STE12 gene, including the stop codon. We used a 5' primer that included 40 bases of the 3' end of YFP in pACL7-YFP-A206K 3 , an AsiSI restriction site, and a single T to make STE12 in-frame with YFP, and we used a 3' primer that included 40 bases downstream of the XhoI restriction site in pACL7-YFP-A206K. We cloned this PCR product, by homologous recombination, into pACL7-YFP-A206K linearized by XhoI. We did this by co-transforming ACL379 with linearized pACL7-YFP-A206K and the PCR product, selecting for colonies that grew on uracil-deficient media, and recovering pRY1001 candidate plasmids 1 from transformants identified by colony PCR. We isolated a plasmid containing the STE12 open reading frame and confirmed the STE12 sequence by direct sequencing. We then PCR amplified and subcloned 1000 bases of DNA upstream of the STE12 start codon, and introduced on the 5' and 3' ends KpnI and EcoRI sites, respectively. We subcloned this PCR fragment into KpnI/EcoRI sites of the recovered and sequenced plasmid, digested this with BglI and isolated the large fragment. We then subcloned this fragment, containing P STE12 -YFP-STE12-TADH1, into the small BglI fragment from a BglI digest of pRS405 plasmid DNA 13 . Finally, we swapped YFP-A206K with CFP (ECFP from Clontech) by subcloning, into the large fragment from an EcoRI/AsiSI digest of this plasmid, PCR-amplified CFP, flanked by a 5' EcoRI sequence and a 3' AsiSI site, to yield pRY1001.
We made pRY1004 in a similar fashion. We PCR amplified DIG1, using a 5' primer consisting of 40 bases upstream of the YFP-A206K start codon in pACL7-YFP-A206K, and an AscI restriction site, and using a 3' primer containing 40 bases of the 5' end of YFP-A206K in pACL7-YFP-A206K. We subcloned, by homologous recombination, this PCR product into pACL7-YFP-A206K that we linearized by digestion with EcoRI. We isolated DIG1-containing plasmids in a manner similar to pRY1001, and confirmed the proper sequence of DIG1 by direct sequencing. We similarly subcloned the DIG1 promoter (1000 base region upstream of the DIG1 start codon) into the KpnI/EcoRI sites of this plasmid, and then subcloned the large fragment of this plasmid digested with BglI into the small BglI fragment of pRS406 13 to yield pRY1004. We then made pRY1004d (pRS406 P DIG1 -Dig1-YFPdark), which is pRY1004 containing a version of YFP with a Q70N mutation 9 , by PCR-based mutagenesis.
To make plasmid PGP1001 we first replaced YFP open reading frame in pRS406-pACT1-YFP 10 with the mRFP 14 open reading. We synthesized a modified open reading frame coding the same mRFP polypeptide, codon optimized for S. cerevisiae. We accepted delivery of this synthesized yeastoptimized mRFP coding DNA from Blue Heron Inc. At a unique Aat II site in the resulting plasmid, we inserted a 222 bp segment of synthetic DNA containing the following elements: 100 bp of the sequence that follows the stop codon of the LYP1 open reading frame, a series of restriction sites and 100 bp of the sequence that precedes the start codon of the LYP1 open reading frame. In pGP1001, the coding strand of the LYP1 sequences was the same as that of the ACT1 sequence.
Single cell microscopy methods
Image acquisition and data analysis
Procedures were built on those in prior work 3, 4, 10 . Briefly, we collected images using a Nikon TE300 inverted fluorescence microscope with a Nikon PlanApo oil-immersion 60X objective (NA=1.4). We controlled bright field and fluorescent lamp shutters (Uniblitz, Rochester, NY), and a six position linear cube changer (Conix Research, Springfield, OR) with Metamorph version 6.2 (Molecular Devices, Sunnyvale, CA), and auto-focused using a custom routine (derived from 4 ) written in Visual Basic (Microsoft, Redmond, Washington).
To prepare cells for measurement, we first sonicated 150 µl of exponentially growing cells (OD 600nm = 0.4-0.8) briefly in 1.5 ml Eppendorf tubes in a Misonix Sonicator 3000 water bath Misonix Inc., Farmingdale, NY) for 30 seconds at output setting 1.0 to separate clumped cells. We then deposited cells into one well of a black-walled, glass-bottomed 96 well sample plate (Arctic White LLC, Bethelehem, PA) that we had pre-treated for at least 15 minutes with 100 µl of 0.1 mg/ml concanavalin V (Sigma) in water. After 10 minutes, we washed immobilized cells three times with 100 µl of media. (We scaled up appropriately for experiments requiring data collection from multiple wells).
We extracted parameters of interest from images using Cell-ID 1.0 15 and analyzed them using Physics Analysis Workstation (PAW) 16 and custom scripts. Image files, Cell-ID input scripts and PAW analysis scripts are available upon request.
For fus3-as2 Δsst2 cells (RY2024), we used the following procedure to reduce the accumulation of hypersensitive Δsst2 cells that accrue loss-of-function mutations in system components that allow cells overcome Fus3-mediated cell cycle arrest. We prepared the cells as above with the following modifications. First, we included 10 µM 1-NM-PP1 in media while growing cells up to a suitable culture density range. We then pelleted the cells gently by centrifugation, washed in synthetic defined growth media without inhibitor, diluted the cells to 0.05 OD600nm, and grew the cells for another 3-4 doublings. We then continued with the experiments as outlined below.
Fluidic control
We constructed a custom fluidic injection and evacuation device 17 to automatically apply liquids to and remove liquids from the bottom of a well in a 96-well glass bottom sample plate. The system consists of a head that holds up to eight 0.1 mm diameter lengths of tubing with ends manually positioned at desired heights above the well bottom. Each of the lines passes through a valve and either terminates in a vial containing pressurized liquid to be applied to the cells, or in a vacuum trap. Media vials are pressurized with 15 psi of compressed air and can inject approximately 100 µl/sec of 1X BSM-2% glucose media containing pheromone and/or inhibitor. The bulk of the head sits in a well adjacent to the well under observation and minimally interferes with the overhead bright-field light source. The tubing is situated along the edge of the observation well and is non-reflective; it does not measurably contribute to background in any of the CFP, YFP, RFP, or FRET fluorescence measurements (data not shown). Valves are controlled using Metamorph. Further details are available upon request.
YFP-Ste5 translocation quantification
Ste5 protein is present at very low numbers. There are ~500 molecules per cell on average, and due to significant YFP fluorophore maturation times, when Ste5 is tagged with YFP only ~350 of 500 YFPSte5 are fluorescent in exponentially growing cells 4 . In these cells, the fluorescence signal from YFPSte5 molecules is barely above background autofluorescence. To increase the signal-to-background ratio, we constructed a strain that expressed two copies of chromosomally integrated YFP-STE5 expressed from native promoter sequences. Doubling the gene dosage increased the signal-to-noise ratio while only modestly perturbing levels of Ste5 and system activity, as reflected by the amount of reporter gene output (about 1.5 times wild-type cells, data not shown).
For each of the time courses presented, we measured at least three observation fields, each containing 20-150 cells, for each stimulus condition. For each time point, we auto-focused, took a 0.25 sec YFP exposure, a focused bright field image (to allow later confirmation of the focus for the timepoint's fluorescence image), and a defocused bright field image (for cell identification and boundary determination). We identified the cell boundaries in the bright field image using Cell-ID, and defined a ring of pixels 1 pixel outside (i.e. away from the cell center) of this boundary as the "membrane region." We manually confirmed that the automatically determined membrane region overlaps with observed fluorescent pixels in images of cells with YFP targeted to the cell membrane (data not shown). We defined the level of membrane recruitment M(t) as the fractional change in total membrane region fluorescence F M from pre-stimulated cells (t=0).
where F M is defined, per cell, as the total fluorescence of the membrane region minus the calculated area of the membrane region times the average extracellular per-pixel-background in the image. We observed that total cellular fluorescence dropped off rapidly for the first 15 exposures and then decayed with smaller percentage per exposure afterward. We attribute this two-phase loss of fluorescence to efficient and rapid photobleaching of auto-fluorescent components in addition to YFP photobleaching for initial exposures, and photobleaching of predominately YFP for later exposures. Thus, for all time courses we collected 15 time points prior to cell stimulation and measurement. We then took two baseline images, stimulated cells with appropriate media conditions, and then took images at indicated times. In order to correct for photobleaching, we performed a double-exponential fit to the median data collected from timecourses in which we did not perform any stimulation (Fig. S3e , gray line). We then subtracted this fit from all of the other timecourses (pheromone, pheromone + inhibitor, inhibitor only, or no treatment; see Fig. S3e ) to produce data corrected for photobleaching as presented in the main text figures. We performed an independent correction based on a "no treatment" timecourse for each experiment in order to minimize effects of variation in lamp strength (and thus variations in photobleaching) between experiments.
The total number of fluorescent molecules at the membrane in the focal plane is quite low. We roughly estimated this number in the following manner. We first estimated the fraction of the cell surface within focal plane, which we estimated for our equipment to be ~2 µm thick 4 . We considered the average yeast cell to be spherical with a 5 µm diameter and a total area of about 80 µm 2 . If the focal plane is positioned to perfectly bisect the cell, the area of this sphere in the 2 µm thick focal plane is ~60 µm 2 . 75% of the total area. If we assumed that 1) upon pheromone stimulation, YFP-Ste5 molecules translocated randomly and isotropically, thus evenly distributing themselves over the interior of the whole cell surface, and 2) after translocation, they are essentially motionless during the course of an exposure (250 ms), then 75% of the total number of YFP-Ste5 molecules are in the focal plane, or about 750 out of 1000 YFP-Ste5 molecules per cell in the 2x YFP-STE5 strains used in this work 4 . Of these, due to YFP fluorophore maturation times (t 1/2 =39 ±7 min for the YFP used in this work in yeast), only 70% of these are fluorescent at any given time in exponentially growing cells 4 , reducing the number of fluorescent YFP-Ste5 molecules in the focal plane to ~525.
FRET quantification
We measured time courses for at least three observation fields, each containing 20-150 cells, for every stimulus and perturbation condition. For each time point, we auto-focused, took a focused bright field image (to allow later confirmation of the focus for the timepoint's fluorescence image), a defocused bright field image (for cell identification and boundary determination), a 0.2 sec CFP excitation image with the emission image split into CFP and YFP emission channels (Dual View image splitter, Optical Insights), and a 0.5 sec YFP excitation/YFP emission image. We used the following filters and dichroic mirrors (Chroma): CFP excitation, 435/40X; CFP emission, 480/30M; YFP emission, 525/30X, 535/20M; beam splitter dichroic, DX505.
For all fluorescence images, to limit fluorophore photobleaching, we used an ND4 neutral density filter. We measured a 1.4% loss of nuclear CFP signal and 0.6% loss of nuclear YFP signal for each subsequent time point. However, as with Ste5 translocation, we observed that some auto-fluorescent components were rapidly photobleached after five initial sets of exposures; during this phase, the calculated FRET exponentially decreases; after the five exposure "pre-bleach", calculated FRET values remain stable for unstimulated cells. Thus, we performed five sets of exposures for each field before data collection. Then, we took two baseline image set followed by an additional set every 30 seconds, with stimulations automatically applied at indicated times.
We define a FRET statistic, F, based on N FRET (Xia and Liu, 2001), with FRET signal (that is, YFP emission resulting from CFP excitation) normalized by both acceptor and donor concentrations. We define F as
We define CY, the corrected signal resulting from illumination at the CFP excitation wavelength and measuring in the YFP emission channel, as
and CC, the corrected signal measuring in the CFP emission channel, is defined as
There is significant CFP emission crosstalk into the YFP emission channel due to its broad emission spectrum ("spectral bleedthrough"); for example, an image of a sample containing purified CFP protein, using CFP excitation wavelengths, will show up as a measurable signal in the YFP emission channel. We measured the emission crosstalk parameter € ACC → CY , the ratio of YFP emission channel signal to CFP emission channel signal for pure CFP emission, for our optical setup using his-tagged CFP that we recombinantly expressed and purified, to be 0.99 (data not shown). BYY to correct for background cellular fluorescence in each emission channel. We calculate these quantities by taking the average fluorescence of pixels in a 1 pixel-wide ring with a radius of 6 pixels centered on the calculated center of the nucleus. This is a reliable per-cell predictor of nuclear background signal; we found that, in wild-type cells with unlabeled Dig1 and unlabeled Ste12, CFP or YFP are relatively flat throughout the cell interior in the CY, CC, and YY channels (data not shown). F is unitless and compensates for differential photobleaching of CFP and YFP by all exposures for a given time point, in the sense that F remains flat for unstimulated cells. For analysis of the Gpa1-Ste18 FRET strain (RY2062b), we performed the procedure outlined above, except that instead of using nuclear fluorescence values for the various wavelength channels, we used fluorescence values from membrane-associated pixels using Cell-ID 4 as described above in the section discussing YFP-Ste5 membrane recruitment.
P PRM1 -(FP) quantification
We performed quantification of fluorescence protein-based transcriptional reporters as previously described 3, 10, 15 , except that did not perform minor corrections for light from out-of-focus regions of the cell. This modification does not effect the conclusions of our work as presented.
MAPK phosphorylation quantification
Protein sample preparation
For each time point, we mixed 1.0 ml of exponentially growing cells (OD 600nm = 0.4 -0.8) with 82.5 µl of 10M NaOH and 10 µl of 100% 2-mercaptoethanol (premixed immediately before the experiment). We incubated samples at room temperature for 5 minutes, added 150 µl of 100% trichloroacetic acid, electrophoresis grade (Sigma-Aldrich, St. Louis, MO), mixed samples well and incubated them on ice for 10 minutes. We then centrifuged samples at >10,000 g for 2 minutes, aspirated the supernatant, incubated the pellet with ice cold acetone for 5 minutes on ice, re-centrifuged to pellet the cells, aspirated the acetone, and allowed the pellet to air dry. We prepared samples for electorphoresis by resuspending pellets in 50 µl of SDS-PAGE loading buffer (10 mM Tris pH 8.8, 0.002% bromophenol blue, 100 mM dithiothreitol, 2% SDS, 50% glycerol) per sample, sonicating to completely disperse cell pellets using a Misonix Sonicator 3000 water bath for 60 seconds at output setting 10.0, and boiling for 5 minutes. Samples were quickly spun at >10,000xg in a microcentrifuge to clear cellular debris before electrophoresis.
Quantitative immunoblotting-electrophoresis, Western transfer, and quantification
We electrophoresed protein samples using 4-15% Tris-HCl/glycine polyacrylamide gels (Bio-Rad, Hercules, CA), then transferred proteins onto 0.2 µm Immobilon-P(SQ) PVDF membrane (Millipore, Billerica, MA) for 45 minutes at 225 mA using a Mini Protean Western transfer system (Bio-Rad). We then blocked membranes for at least 1 hour at room temperature in Tris-buffered saline (TBS, 10 mM Tris pH 7.4, 150 mM NaCl) plus 1/10 th volume of Western Blocking Reagent (WBR) (Roche, Alameda, CA). We first quantified both phosphorylated and total Fus3 and Kss1 by simultaneously probing with rabbit anti-phosphoP44/P42 #9101L at 1:1000 dilution (Cell Signaling Technology, Danvers, MA), goat anti-Fus3 #sc6773 at 1:500 dilution (Santa Cruz Biotechnology, Santa Cruz, CA), and goat anti-Kss1 #sc6775 at 1:200 dilution (Santa Cruz Biotechnology) overnight at 4 °C, diluted 1:1000, 1:500, and 1:200 respectively in primary antibody binding buffer (TBS, 1/10 th volume WBR, and 0.05% Tween). We then washed blots in TBS and probed for 1 hour at room temperature with 800 nm donkey antirabbit #611-731-127 (Rockland Inc., Gilbertsville, PA) and 680 nm donkey anti-goat A21084, fluorophore-conjugated secondary antibodies (Invitrogen, Carlsbad, CA) , diluted 1:10,000 in secondary antibody binding buffer (TBS, 1/20 th volume WBR, 0.025% Tween and 0.01% SDS). Blots were washed in TBS then scanned on a LiCor infrared imaging system (Li-Cor Biosciences, Lincoln, NE). We then prepared blots for quantifying PGK as a loading control using mouse monoclonal anti-PGK1 A-6457 (Invitrogen), either by probing identically prepared transfers or by stripping previously probed blots by shaking in stripping buffer (62.5 mM Tris pH 6.8, 2% SDS, and 100 mM 2-mercaptoethanol) at 50 °C for 30 minutes, washing extensively with TBS, and re-blocking. Before re-probing, stripped blots were scanned to ensure that >95% of previously observed signal was removed at regions around PGK (~50 kDa apparent mobility). We then probed with mouse anti-PGK for 1 hour at room temperature, followed by 800 nm donkey anti-mouse secondary antibody #610-731-124 at 1:10,000 dilution (Rockland), washed, and scanned as described above.
We quantified band intensities using Odyssey v1.2 (Li-Cor Biosciences) using median top/bottom background correction.
mRNA quantification by ribonuclease protection assay
We treated 10 ml of exponentially growing cells with 100 nM pheromone, and then separated cells from media by vacuum filtration onto 0.45 µm filter discs (Millipore). We put the discs with cells into 1.5 ml Eppendorf tubes and flash-froze at the indicated times after stimulation with pheromone by immersing open-capped tubes in liquid nitrogen. For total RNA extraction, we thawed samples on ice and used RiboPure Yeast kit (Ambion, Austin, TX). We broke cells open using a Mini-bead-beater-8 (Biospec Products, USA) using 400 ul of 0.45 µm glass beads (Sigma) by agitating for 1 minute. We generated radioactive probes for ACT1 (loading control) and FUS1 using αP 32 dCTP (GE Healthcare) and performed ribonuclease protection assays using a RPA III kit (Ambion, Austin, TX). We electrophoresed samples on a 5% TBE/polyacrylamide gel, dried the gel for 1 hour at 65 °C, and exposed the gel to a phosphorimaging plate (GE Healthcare) for 12 hours at room temperature. We scanned the plate on a Storm scanner (GE Healthcare) and quantified bands using ImageJ 18 .
RY1130b (FRET strain) characterization
The strain with the best loss of FRET signal responded normally to pheromone in terms of growth arrest ( Fig. S5a and Supplementary Information 5). The sensitivity (EC50) of the response using transcriptional reporter gene expression assays was similar to the response in reference strains with unlabeled Dig1 and Ste12. The relative magnitude of the response was about three times higher at all doses (Fig. S5b) . We found that this reporter strain and derivatives (RY1130 and related strains) expressed levels of Ste12 protein consistent with multiple (three) integrated copies of CFP-STE12 (Fig.  S5c) . Levels of nuclear CFP fluorescence remained stable over many rounds of cell division and many months of laboratory manipulation, indicating that the cells stably maintained multiple CFP-STE12 copies (data not shown).
Pheromone-induced loss of FRET is dependent both on the presence of Ste5 (Fig. S7c ) and on MAP kinase activity (Fig. S7d ). Based on median nuclear CFP fluorescence values (see Supplementary Table  S3 ) from RY1100 (ΔDIG1 ΔSTE12), RY1130b (base FRET strain), and RY2025 (FRET strain with Dig1-YFP replaced by Dig1-YFPdark at equivalent protein levels, see Supplementary Fig. S7c ), we estimate the average FRET efficiency,
where CC DA is the nuclear fluorescence of the donor in the presence of an acceptor (RY1130b) and CC A is the nuclear fluorescence of the donor without an acceptor (RY2025), corrected for autofluorescence values (RY1100), in un-stimulated cells to be approximately 8% (data not shown). This is consistent with FRET efficiency estimates based on acceptor photobleaching studies (data not shown).
Measurement of dose-responses using high throughput flow cytometry 6.1 Pheromone induction in multiwell plates
We performed flow cytometry experiments in 1 ml-capacity 96-well polypropylene plates. We first sonicated exponentially growing cells in individual 1.5 ml microcentrifuge tubes, as described above. We then added 10 µl of sonicated cell culture to 200 µl of media with 0.15X Dulbecco's phosphatebuffered saline and 20 µg/ml casein (Sigma) containing 5 µM 1-NMPP1 (to inhibit cdc28-as2) and the appropriate concentration of pheromone. We incubated plates at 30 ºC in an air-heated shaker rotating at 300 rpm. After 3 h, we added 10 µl of 500 µg/ml cycloheximide. We incubated the plate for at least 5 h to allow for complete maturation of the fluorescent protein fluorophores. Within that time period we sonicated the plate. We drilled 3/8" holes in each of the corners to ensure that all the liquid in all wells were completely submerged in the sonicating bath. We then sonicated as described above, except we that sonicated for two minutes at power 8.
High throughput sampling into the flow cytometer
We transferred the cycloheximide-treated cells to 350-µl capacity 96-well polycarbonate plates. We moved individual wells into the flow cytometer using a custom-built, attached high-throughput sampler (HTS). The HTS was set to high-throughput mode and programmed to mix the well and collect 5 µl in 10 seconds (500-5000 cells), followed by three 200 µl washes.
Flow cytometric measurements
We used a Becton-Dickinson LSRII flow cytometer equipped with a 100 mW 488 nm laser and a 150 mW 532 nm laser. All filters and dichroic mirrors were from Chroma.We used a threshold value of forward scatter (FSC) from the 488 nm laser to trigger data collection. We calibrated threshold values of FSC to detect the smallest cells in an exponentially growing culture of wild type yeast cells or equivalent. We measured YFP and mRFP fluorescence from the light emitted during the 532 nm excitation, which was channeled, using mirrors, into an octagonal array of 8 photomultiplier tubes (PMTs), labeled A to H. Light entering the array is first split by a 735 nm long-pass dichroic mirror (735LP) and then split again by a 640 nm long-pass dichroic mirror (640LP). The light that goes through the 640LP dichroic is filtered through a 675 nm band-pass filter of 50 nm wavelength width (675/50) before hitting the B PMT. The lower wavelength light that reflect in the 640 LP dichroic is directed towards a 600LP dichroic, the reflected light is split by a 540LP dichroic. The light that goes through the 540LP dichroic is filtered through a 550 nm band-pass of 10 nm width (550/10) before hitting the D PMT.
We took the signal from the B PMT as the fluorescence from mRFP. Cells expressing only YFP or CFP show the same signal in this channel as wild type cells. We took the signal from PMT D as the fluorescence from YFP. Cells expressing only mRFP or CFP show the same signal in this channel as wild type cells.
Hill function fits and parameter calculations.
We fit data with Hill functions and calculated EC50 and Hill coefficient values using commercial software, Prism 4 (Graphpad Software Inc., San Diego) and ProFit (QuantumSoft, Uetikon am See, Switzerland). Using default settings and similar initial values for fitting routines, we calculated essentially the same values described in the text using either program.
How negative feedback can improve information transmission
Here we discuss how negative feedback help stabilize output (and thus increase the signal-to-noise ratio) of biological systems , which can have substantial cell-to-cell variation in component number 19 ; for example, we have observed significant cell-to-cell variation in protein levels of components in the yeast pheromone response system (Thomson, personal communication and 4 ), as well as increase the signalto-noise by increasing the dynamic range of the output relative to noise in the output.
Negative feedback makes system output robust to variation in component properties
Negative feedback can stabilize the input-output relationship of a system given substantial variation in component properties. This fact, and its relevance to design of electronic amplifiers, was noted by Harold Black 20 . Savageau 21 , in a theoretical study, analyzed how, in a transcription system expresses its own repressor, the system's negative autoregulation decreases the variability of repressor protein output levels. Experimental analyses of synthetic gene regulatory circuits confirmed this concept 22 . In a theoretical study, Barkai and Leibler also proposed that non-transcriptional negative feedback stabilized output of biochemical networks, such as in the two-component signaling system that mediates bacterial chemotaxis 23 .
Negative feedback can bring about dose-response alignment without eliminating output dynamic range
A classic analysis of operational models of multi-step biochemical systems 24 indicated a tradeoff between dose-response alignment of upstream and downstream responses and the dynamic range of the downstream response. A reduced output dynamic range reduces the signal-to-noise ratio in systems where output has a minimum level of noise that does not scale with system output. Specifically, Black and Leff analyzed a series of operational models of pharmacological agonist and related applied agonist dose to the observed effect 24 . We show in Fig. S1 a simple model from their work of a response system with two signaling steps. Each step is a mass-action-based reaction that we describe by a hyperbolic, Michaelis-Menten-form relationship.
Eq. 8.1 describes the dose-response of the first step, receptor-agonist binding, where [AR] is the concentration of agonist-receptor complex, [R 0 ] is the concentration of total receptor, [A] is agonist concentration, and K 1 is the dissociation constant for this interaction.
Eq. 8.2 describes the second step, formation of the agonist-receptor-transducer (ART) as a function of AR, and the effect (E), which is proportional to the concentration of ART. K 2 is the dissociation constant of this reaction.
Black and
Dose-response alignment, as we discuss in this work, manifests in this system when the EC50 of the effect E as a function of agonist concentration approaches EC50 of the first step (i.e., K 1 ). The slopes match because the dose-responses of [AR] and [ART] and hyperbolic (i.e., have the same Hill coefficient).
Black and Leff showed that the concentration of agonist yielding half-maximal effect E is
This relationship shows that, as the doses align (EC50 approaches K 1 ),
The magnitude of the maximal effect, E max , is defined by
Thus, as dose-responses align and
Dose-response alignment is equivalent to saying that there is a linear transfer function between [AR] and E. However, as defined in Eq. 8.2, the transfer function between [AR] and E is hyperbolic. One way to get a linear response from a hyperbolic transfer function is to only sample a very small part of the transfer function with small values of [AR] . In this range of input, the transfer function is approximately linear, but then the outputs are accordingly restricted to small values.
Application of metrics from information theory to quantify how well cell signaling systems transmit information about external conditions
Mutual information from information theory 25 can quantify how well a cellular signaling system can transform inputs, such as a distribution of receptor occupancies in pheromone response, into distinguishable outputs, such as corresponding distributions of output from a transcriptional reporter gene.
In the continuous case, we compute mutual information (in bits) based on the following definition: 
The mutual information captures how the graded-ness of the response and the noise of the response impact the overall ability of cells to distinguishably respond to different external pheromone concentration. For example, consider two cell types, each with the same graded pheromone-receptor binding response. A cell with low transmission noise but an extremely switch-like downstream response has a reduced ability to respond differently to different doses, because all inputs are restricted to only one of two responses. On the other hand, a cell with a graded downstream response and high transmission noise also has a reduced ability to respond differently to different doses, because transmission noise increases the variation in the responses, making it harder to determine if a given response is associated with a particular input. The diminished ability to respond distinctly to a particular set of input pheromone concentrations would be reflected by lower mutual information scores calculated for both cell types.
Mutual information also quantifies how the actual choice of pheromone concentrations the system is responding to affects the ability of the system to generate distinguishable responses. For example, if we stimulate the system using input concentrations that yield saturated responses (such as stimulating Δsst2 cells with pheromone concentrations that are within the dynamic range of receptor occupancy but saturate the downstream response), then the responses are nearly indistinguishable, and provide little information about the external pheromone concentration. In this case, the mutual information would be low.
A special case of mutual information called the channel capacity (Part IV, section 24 in
25
). This represents how much information the system can transmit considering all possible input doses. This metric reflects the fundamental ability of a system to transmit information about external conditions given an ideal input distribution. For example, we expect that the channel capacity of the pheromone response system in Δsst2 cells is lower than that in wild-type cells because of dose-response misalignment; using the channel capacity, we could quantify exactly how much worse in a more "absolute" sense. Likewise, if we choose doses such that they are distributed where the response is not saturated, we expect that small changes in input dose will be more distinguishable by the respective outputs.
Using these metrics allow one to quantitatively compare how well different systems can distinguishably and precisely respond to different inputs, as well as measure how much molecular mechanisms, such as Fus3-mediated negative feedback, affect the ability of systems to transmit information, such as external pheromone concentration. All strains derive from ACL379, a W303 derivative, as described above. we performed a per-pixel subtraction of the time zero image from the end time point image. We adjusted the pixel intensity display scale to extend from maximal increase (white) to maximal decrease (black), centered on zero change (gray). We did not enhance the contrast of the images by any other processing. b) Signaling in fus3-as2 and kss1-as2 is inhibited by 10 µM 1-NM-PP1. Shown are mean (+/-SE) total system output for indicated strains (n>100 for each) after 1 hour of stimulation by pheromone. We observed a slight signal increase in cells without inhibitor-sensitive proteins when they were treated with inhibitor. 
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